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ABSTRACT
CHARACTERIZING COLORECTAL CANCER CELLS AND
THEIR INTERACTIONS WITH POLYMETHOXYFLAVONES
BY RAMAN MICROSCOPY
SEPTEMBER 2016
HUA ZHANG
B.E., NORTHWEST A&F UNIVERSITY, SHAANXI, CHINA
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Hang Xiao and Lili He

Polymethoxyflavones (PMFs), especially Nobiletin (NBT) and 5demethylnobiletin (5DN), have been widely studied and proved to have anti-cancer
effects. However, their exact modes of action against cancer cells are not fully
understood. Raman spectroscopy is a molecular vibrational spectroscopy can be used to
measure overall biochemical function of single cells noninvasively and without adding
any chemical labels. Herein, we characterized the cellular responses of human colorectal
cancer HT29 and HCT116 cells, that grow on the gold coated slides, to the treatments of
NBT and 5DN using Raman microscopy. Raman microscopic images obtained indicated
the different modes of action of these two PMFs against colorectal cancer cells. NBT
induced more changes in the nucleic acid peaks and protein peaks, while 5DN induced
more changes in the localized lipid peaks.
We further analyzed both attached and floating cells in response to NBT and 5DN
treatments using Raman microscopy and principal component analysis. Result showed
vi

large spectral heterogeneity of floating cells compared to attached cells, particular in the
range for protein spectral profiles. In response to the treatment s, the difference between
the floating cells and attached cells became smaller over time. This indicates the different
sensitivity and behavior of individual cells to the treatment.
Identification of individual cancer stem cells (CSC) from normal cancer cells is
challenging. We applied Raman microscopy to identify and characterize CSC. CSC were
enriched in non-attachable petri-dish to form cell spheres. The spheres containing both
CSC and normal cancer cells and could be separated based on the density. It is interesting
that 70% of CSC enriched density layer produced a distinct Raman peak at around 1049
cm-1, while almost no normal cells contained this peak. This finding demonstrates the
1049 cm-1 peak might be used as indicator peak for CSC. Further validation is needed.
Overall, our research demonstrates the feasibility of Raman microscopy to characterize
individual cells and to investigate the heterogeneous response of the cell population to
treatment. Moreover, there is a great potential of using Raman microscopy for identify
individual CSC from normal cancer cells and investigate their heterogeneous response to
the treatment.
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CHAPTER 1.
INTRODUCTION
Cancer burden is still increasing worldwide. It now affects 24 million people
around the world resulting in 6 million death annually. The increased aging populations
as well as adopted cancer-causing habits leads to more cancer incidents in developing
countries1. In the United States, cancer continues to be a major public health problem.
Among the population ages between 45-64 years old, cancer is number one leading cause
of death and the second to heart disease in the older populations (National Center for
ealth Statistics, CDC). Within one’s lifetime, individual have approximately 40% chance
to be diagnosed with any type of cancer. Cancer, especially colorectal cancer, is
normally considered to be a severe disease that has been the leading death cause in the
US for successive years. Colon cancer affects million people annually and the overall
survival rates for patients is just about 65%2. The serious situation attracts great attention
from the scientists.
A major reason about how the recovery rate of cancer patients after scitific proved
therapy is below expectation is probably due to the cancer cell heterogeneity3. Cancer is a
combination of differentiated malignant cells. Though studies discovered increasing number
of great findings to eliminate one kind of cancer cells every year, there is still almost no sign
of stopping cancer from growing more serious. In a tumor or even in the same cancer cell
line, the existence of subpopulations of cells always interfere with the interaction between
treatments and cancer cells reactions. The heterogeneity of cells requires the treatment to
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display a broad spectrum anti-cancer ability to eliminate the entire cancer cell population to
prevent them growing back. Due to this situation, studies of cancer cell heterogeneity is of
great importance. Firstly, It could help determine the heterogeneity of the cancer cells. A
better understanding of the heterogeneity of cancer cells would help determine the
effectiveness of treatments. Secondly, it would provide the information about how the
treatment interacts with the entire cancer population. The heterogeneity change of the cells
could reveal the mechanism of interaction. In summary, it could monitor the cell
transformation due to the time or stimuli change to keep tracking the key factors.

Within the existing causes of the heterogeneity including genotypes and
phenotypes, the cancer stem cells are highly believed to be the main reason4. Cancer stem
cells are a kind of cells existing among cancer cells that possess the ability of self-renewal,
generating daughter cell and differentiation. Besides, cancer stem cells are always considered
with higher resistance to therapy5. Therefore, the elimination of cancer stem cells might
inhibit the cancer proliferation and be the key of defeating cancer. Current identification
method of cancer stem cells is by their cel-surface-marker expression. However, the cellsurface-marker is not a universal method to identify cancer stem cell yet, therefore the
isolation of cancer stem cells continues to be a big challenge. In a word, an effective and
reliable method of isolating and identifying cancer stem cells is in need. With the isolated and
purified cancer stem cells, more specific studies could be conducted which would benefit the
studies of cancer stem cell treatments.

Flavonoids, which are rich in fruits and vegetables, have long been believed to
display biological health-beneficial effects. Among all these flavonoids, scientist found
several specific types possessed the great anti-cancer property, and one of these types is
polymethoxyflavones (PMFs). PMFs, which exclusively exist in the citrus genus,
2

especially abundant in sweet orange (Citrus sinensis (L.) Osbeck) and mandarin (Citrus
reticulate Blanco). 6 This specific type of flavones has attracted great attention due to
their broad spectrum of biological activities, including anti-inflammatory7,8, anticarcinogenic9,10 and anti-oxidant 11,12. In this study, we mainly focused on the anticarcinogenic property of the PMFs. The hydroxyl-PMFs could also be extracted from the
citrus genus and showed anti-carcinogenic properties13 as well. Many studies proved that
hydroxyl-PMFs showed greater bioactivity than their counterpart PMFs6. In this study, we
picked two representative PMF and hydroxyl-PMF namely nobiletin(NBT) and 5-

demethylnobiletin (5DN) to study the mechanisms of the inhibition effect of these PMFs
to the cancer cells.
Raman spectroscopy is a vibrational technique has been widely applied for molecule
identification and structural characterization. It provides molecular ‘fingerprint’ about
structural information of analyte molecules. Raman spectroscopy is non-destructive and
rapid. Raman microscopy combined Raman spectroscopy with microscopic technique. The
application of Raman microscopy on the cells enabled people to image the distribution of
biochemical composition in a single cell and study its chemical profile changes due to the
stimuli. The advantages of non-label and non-destruction of the technique simplified the
sample preparation and protected the integrity of the cell.
The overall objective of this project is to characterize colon cancer cells and their
interactions with PMFs by Raman microscopy. Our central hypothesis is Raman microscopy
can be used for study the modes of action of PMF against colon cancer cells based on single
cell imaging. The Raman spectra collected from a population of cells can be used for
analyzing the heterogeneity in the population and their response to treatment. Moreover,
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Raman microscopy could also identify the difference between normal cancer cell and cancer
stem cell.

Take all these into consideration and to test our hypothesis and achieve our
objectives, we conducted the research by following specific aims:
1. Label-free Imaging and Characterization of Cancer Cells Responses to
Polymethoxyflavones Using Raman Microscopy
In this study, we characterized the responses of cancer cells to NBT and 5DN
using Raman microscopy. Flow cytometry analysis of the cell cycle was also performed
to determine the effects of PMFs on cell availability. Cells were grown on gold coated
slides and measured using Raman microscopy. Combined with the cell cycle result and
the Raman cell image, the mechanism of the interaction between cancer cells and PMFs
could be revealed.
2. Characterizing Heterogeneous cellular responses to Polymethoxyflavones
Using Raman Microscopy.
In this study, we studied cell heterogeneity of both floating cells and attached
cells in response to NBT and 5DN over time. With the Raman spectra and principal
component analysis score provided by Raman microscopy, we could analyze the
heterogeneity of the cells before, during and after treatment. It would help to analyze the
cell heterogeneity.
3. Isolation and Characterization colorectal cancer stem cells using Raman
microscopy

4

In this study, we developed a more efficient way to isolate colorectal cancer stem
cells from normal cancer bulk cells by cell density and characterized the cancer stem
cells using Raman microscopy. The stemness of the cells were determined by Extreme
Limiting Dilution Analysis (ELDA). Combined with the Raman spectra and ELDA, the
goal of isolation and identification of cancer stem cells had been achieved.

5

CHAPTER 2.
LITERATURE REVIEW

2.1 Polymethoxyflavones
2.1.1

Introduction to polymethoxyflavones

Increasing number of studies suggesting the beneficial effects of diet abundant in
fruits and vegetable. Among all the beneficial effects, anti-carcinogenic14,15, antiinflammatory16,17 and antioxidant18,19 are the most presented in these bioactive foods.
Most of the beneficial effects are believed to link to the existence of flavonoids, also
various kinds of flavonoids showed distinct bioactive abilities. Flavonoids is a molecular
that structures arranged in a C6–C3–C6 configuration. More than 4000 unique flavonoids
have been identified in plants. The flavonoids could be subdivided into 12 subclasses,

Figure 2.1 Chemical structures of major PMFs, namely nobiletin (NBT), 3’hydroxylnobiletin , 4’-hydroxylnobiletin, 3’, 4’-dihydroxylnobiletin, 5-hydroxylnobiletin
(5DN), 5, 3’-dihydroxylnobiletin, 5, 4’-dihydroxylnobiletin, and 5, 3’, 4’triihydroxylnobiletin.

including flavonols, flavones, flavanones, flavanols, isoflavones, flavanonols, chalcone,
and anthocyanidins.
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Citrus including oranges, lemons tangerines,, limes and grapefruits, are widely
consumed and have become an important part of daily diet. In 2013-2014, current annual
citrus production in the United States was 17,800,000 boxes , according to the National
Agricultural Statistics Service. The leading state is Florida constituting 65% as, followed
by California, Texas and Arizona. About 30% of the citrus was used for juice production
to generete 4-5 billion lbs. The by-products citrus peels are processed to obtain the
volatile and nonvolatile fractions in many areas including food, pharmaceutical and
cosmetic industry. In China, aged citrus peels have been utilized as traditional medicine
since ancient times to treat various diseases. Its outstanding effect on diseases including
abdominal fullness and distention, cough, and hypertension made it popular for daily
consumption. In addition to the effects on the diseases, citrus fruits contain considerable
amount of vitamins and flavonoids, carotenoids, and limonoids. The PMFs is a unique
class of flavonoids bearing two or more methoxyl groups on their basic heterocyclic C6–
C3–C6 skeleton with a carbonyl group at the position 4(Figure 2.1).
Polymethoxyflavones (PMFs), which is a unique class of bioactive flavonoids (Chemical
structure showed in Figure 2.1), have been received particular interest during recent
years. They are almost exclusively found in the citrus genus and more than 20
polymethoxylated flavonoids being isolated and identified. Recent studies showed it
possessed a broad spectrum of biological activities including anti-inflammatory7,20,
antioxidant12, anti-atherogenic, antimicrobial and anti-carcinogenic21,22.
Anti-inflammation studies suggested that PMFs obtain promising antiinflammation ability. In a study focused on the anti-inflammation ability of nobiletin,
TPA, which could induce O2- production and skin edema formation in mice, was used to
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cause mouse skin inflammation. The result suggested that nobiletin treatments 30mins
before each TPA application(twice in total) showed the highest inhibition of H2O2
production and most effective of edema suppression(Figure 2.2)8 than the other TPA
applications. The nobiletin mechanism was believed to be the inhibition of the release of
both LPS-induced and IFN-γ-induced TNF-α and IL-1β. It suggested that PMFs is an
effective anti-inflammation flavonoid.
Anti-oxidant studies suggested PMF could provide the great protective ability to
cells from oxidative damage. A previous study used H2O2- treated PC12 cells as oxidative

Figure 2.2 Suppression by nobiletin of TPA-induced skin morphological changes
observed by H&E staining. Ac: Acetone. TPA: TPA induced. NOB, nobiletin.

damage cells to determine the anti-oxidation ability of PMFs. The
malondialdehyde(MDA) level could measure the effectiveness, which indicates the free
radical activity, and the antioxidant enzyme activities including SOD and GSH-Px. The
results showed that certain PMFs could decrease the MDA levels and also improved the
activities of SOD and GSH-Px23, suggesting the antioxidant effectiveness of PMFs.
8

Antimicrobial is another major bioactive ability of PMFs that attracted attentions
from researchers. In a study, the ability of PMFs against Pseudomonas was studied. The
study used nobiletin and tangeretin and the SEM and TEM images showed their abilities
to destroy the permeability of the cell membrane. Furthermore, nobiletin and tangeretin
also could inhibit the protein synthesis. The inhibition of protein synthesis would cause
metabolic dysfunction, and eventually to cell death.24 The result suggested the
antimicrobial potential of PMFs.
Table 1 . Effects of different drugs on activities of SOD, MDA, GSH-Px in H2O2-treated
PC12 cells.

There are also many studies focused on other areas, as PMFs are such a type of
flavonoids that possessed many effective bioactivities. In a word, it is necessary and
important to study the PMFs. Furthermore, all the anti-inflammation, anti-oxidant and
antimicrobial and other bioactivities are always linked to the property of anticarcinogenic.
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2.1.2

Anti-cancer effect of polymethoxyflavones

Take the anti-carcinogenic property particularly; there are many types of research
related in vivo or in vitro. Studies showed that PMFs could induce cell apoptosis, cell
cycle arrest, and cell anti-proliferation in cancer cell population. Xiao et al. reported that9
the interaction between lung cancer cells and two major PMFs plus two major
monodemethylated PMFs. The study showed that monodemethylated PMFs could induce
better growth inhibition of lung. Cell cycle analysis and apoptosis analysis revealed that
different PMFs showed different inhibition mechanism when treated H1299 cells. Qiu et
al. 25 focused her study on the three major PMFs and their 5-hydroxy counterpart on
human colon cancer HCT116 and HT29 cells. Cell cycle analysis and apoptosis results
suggested that 5-Hydroxy PMFs showed much stronger inhibitory effects on the growth
of colon cancer. The mechanism of action was revealed to be apoptosis and cell-cycle
arrest induced by p53-, Bax- and p21-dependent.26 Besides, related animal study27 was
conducted. The result suggested that dietary consumption of hydroxylated PMFs could
induce significant inhibition of AOM- induced ACF formation in mice.
Oral consumption of NBT could also effectively inhibit colitis-associated colon
carcinogenesis in mice.28 The histopathological and immunohistochemical analysis
showed that PMFs could maintain the histological characteristics of normal mucosa and
decreased the number of PCNA positive colonocytes. PCNA is a cofactor of DNA
polymerase (As showed in Figure 2.3).
In summary, PMFs could inhibit many types of cancers including lung cancer,
breast cancer and colon cancer.
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2.1.3

Biotransformation of polymethoxyflavones

Increasing number of evidences suggested that biotransformation played
important roles in the biological activities of orally administered compounds29,30. Studies
proved that the metabolites generated in the body by the biotransformation showed more
potent bioactivities compared to their parent compound. Also oral consumption of a
parent compound may result in higher levels of metabolites. Therefore, the metaboliteds
exhibit dominant effects under the aforementioned circumstance in those tissues 31. In
recent years, though considerable amount of studies about the biological properties of
PMFs have been reported, knowledge of their biotransformation profile is still limited.
Previous studies suggested that the primary sites of biotransformation of PMFs are 3’ and
4’ positions on the B-ring. The number and position of the hydroxyl and methoxyl groups
on the B-ring would affect the metabolism and biological activities of PMFs
significantly.
Nobiletin is a major PMFs compound. Many studies had reported itsbioactivities
(5,6,7,8,3’,4’-hexamethoxyflavone, NBT) . It has been found to exert various protective
effects against various cancers in animal models. In particular, previous studies have
showed that dietary administration of NBT effectively suppressed colon carcinogenesis in
three different colon cancer animal models32,33. The studies suggested that dietary
consumption of NBT possess the inhibition effect on colon carcinogenesis induced by
colon carcinogens in vivo.
Among different types of PMFs, 5-hydroxylated PMFs are a unique subclass. 5demethylnobiletin (5DN) is an important 5-hydroxylated PMF, that has been
demonstrated the anti-carcinogenic properties against lung and colon cancer21.
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Although the abundance of 5-hydroxylated PMFs is relatively less compared to their
permethoxylated counterparts. Some previous studies demonstrated that 5DN exhibited
superior anticancer potential than their counterparts against multiple types of cancers.
The result indecated higher inhibition potential to the cancer cells than the NBT. It also
suggested that demethylation at 3’ position may contribute to the enhancement of the
growth inhibitory effects on colon cancer cells.

Figure 2.3 Histological characterization of colonic mucosa and tumors of AOM/DSStreated mice. (i) H&E staining of colonic tissues of the control (A) and NBT-treated (B)
groups (magniﬁcation: 100×); (ii) PCNA staining of colonic mucosa of the control (C) and
N BT-treated (D)groups (magniﬁcation: 400×); (iii) cleaved caspase-3 staining of colonic
tumors of the control (E) and NBT-treated (F) groups (magniﬁcation:400×); (iv)
quantiﬁcation of PCNA-positive and caspase-3-positive cells in colonic mucosa and
tumors (G);*statistical signiﬁcance with p < 0.01, n = 6.
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2.2 Colorectal cancer
2.2.1

Introduction to colorectal cancer

Colorectal cancer is always the second-leading cause of cancer death in the US.
According to the data (Figure 2.4) collected by National Cancer Institute, the Centers for
Disease Control and Prevention and the North American Association of Central Cancer
Registries. Estimated new cases and estimated deaths of 2016 was 8%, as showed in
Figure 2.4 34. It is about 134,490 estimated new cases and 49,190 estimated deaths. That

Figure 2.4 Ten Leading Cancer Types for the Estimated New Cancer Cases and Deaths
by Sex, United States, 2016.
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remained to be a large population compared to the increasing amount of research work
regarding on characterization and prevention of colorectal cancer has been done. The
importance of better understanding the cancer cells remained.
Colorectal cancer starts as polyps or adenomas on the surface of the upper layer
and develops to grow into underneath layer. Later on, cancer cells invade the body
furthermore. The different cancer development phases could be classified into four
stages. Stage 1, cancer cells are in the inner layers of the colon; stage 2, cancer cells
spread through the muscle wall of colon; stage 3, cancer cells spread to the lymph nodes
and stage 4, cancer cells metastasized to other organs.35 Epidemiological studies have
proved that the occurrence of colorectal cancer is possibly related with inherited cancer
predisposition syndromes, and some other risk factors, such as high fat diet, smoking,
environmental procarcinogens, alcohol consumption, inadequate intake of vitamins and
dietary fiber, and lack of physical exercise36,37.

2.2.2

Biological studies of colorectal cancer

The modern idea of how cancer produced is when tumor progression initiated in
one cell and experiences a series of random DNA mutations. After these random
mutations, cells possessed the property to proliferate and survive and then became the
malignant phenotype.38 To study the process, numerous studies about cancer cells have
been discovered and utilized in recent years.
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2.2.2.1

MTT study

Most studies are focused on the interactions between treatments and cells to
further understand the possibilities of eliminating cancer cells. The 3-(4,5imethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay is a method that
utilized in most widely used methods for drug analysis39. The same cell amount would be
cultured in the 96 well plate wells, and the MTT result relies on the cell survival
percentage. Seed the cells in the 96 well plates and culture the cells to make the cells
attach on the surface of the petri dish. When the cells attached to the surface of the Petri
dish, the media containing the treatment would be added in the cell containing petri dish.
After treated the cells with certain time and dose, the MTT dye would be added to the
petri dish to replace the cell media. Discard the floating cells and the attached live cells
would remain in the petri dish. In this way, the live cells would be dyed with MTT color
and became dead. Replace the dye solution with a solvent to dissolve the dye from the
cells. Color absorption could determine the cell live percentage. Based on the dose and
treatment time, the drug effectiveness to the cells could be determined.

2.2.2.2

Cell Cycle Study

For further analysis of the interactions between cells and the drugs is the cell
cycle study40,41. In a cell cycle, the status of the cell would be divided into different
stages: G0/G1 phase, S phase, G2 phase and M phase. Cell cycle analysis plays an
essential role in drug development of most cancers. In the G0/G1 phase, the cell would be
rest and prepare for the cell division. When a mitotic signal is triggered, cells leave G0
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phase, a quiescent state, and enter into the G1 phase, an active state. In the S phase, cells
start to replicate the DNA.In G2 phase, cells grow bigger and are ready for the division.
At last at the M (mitosis) phase, cells divide into two cells, and the cells would enter
another cycle.
When cells treated with certain treatments, the cells would stop at a certain cycle
phase namely cell cycle arrest. The cell cycle arrest result will provide information about
the reaction mechanism between drug treatments and cells. It would provide much help to
study the drugs. The whole process needs the DNA of the cells to be labeled and scanned
by flow cytometry. By determining the degree of the DNA content, the cell cycle status
would be confirmed.

2.2.2.3

Cell Apoptosis Analysis

Another approach that could be applied to the interactions studies is apoptosis
analysis42,43. Apoptosis is a process of programmed cell death. There are many
biochemical events could lead to cell morphology and death. Cell apoptosis is
unstoppable once the procedure begun. Apoptosis can be initiated in two ways, including
intrinsic pathway and extrinsic pathway. The intrinsic pathway was the cell dead when
the cells sensed pressure. For extrinsic pathway, cells dead when the cells got the signal
from other cells. Cell apoptosis study is a method to study the initial of apoptosis. By
understanding the apoptosis pathway, we could study the reaction mechanism of the
treatments. We could also associate the effects of treatments with their ability in
modulating key signaling proteins related to cell proliferation and apoptosis, such as
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p21Cip1/Waf1, cyclin-dependent kinase (CDK)-2, CDK-4, phosphor-Rb, Mcl-1,
caspases 3 and 8, and PARP. By inducing the apoptosis in cancer cells, it would be an
effective method to control cancer cell growth. The apoptosis analysis is still in need of
labels with Annexin V and propidium iodide.

2.2.2.4

Western Blot Study

Western blot could study the protein change due to the interactions44,45. The
western blot is an analytical technique that had been widely applied to study specific
proteins in the cell or tissue sample. To do the western blot analysis, the gel
electrophoresis it needed to separate the protein by 3-D structure or denatured protein by
the polypeptide length. Then, the target protein would be stained with specific antibodies.
As showed in Figure 2.5, with the utilization of western blot, the cell apoptosis analysis
could be confirmed, and compare the protein content.

2.2.2.5

ELISA

To further understand the mechanisms, usually conducted inflammation
studies.The inflammation studies use the enzyme-linked immunosorbent assay (ELISA)
to analyse the protein type and content. ELISA is a method to uses an enzyme
immunoassay to detect and identify the presence of a substance46,47. ELISA had high
sensitivity and had been widely used in many areas. When performing an ELISA,
antigens are attached to a surface then add the specific antibody over the surface to let it
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Figure 2.5 Western blot demonstrated that combined treatments with
atorvastatin/celecoxib for 48 hr activated caspase cascade. b-Actin served as an equal
loading control. The results were representative of 3 experiments.

bind to the antigen. At the other end of the antibody, an enzyme linked. With the
enzyme’s substrate containing substance added as a final step. In the end, the subsequent
reaction would be determined by the substrate color change. Once the mechanism of the
bulk cells had been studied and analyzed, usually conduct further researches like
transwell study combined with Caco 2 cells.
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Based on these biological approaches, there is a fact we found about previous
studies was that they usually take cell population into consideration instead of the
individual cells26,48,49. The methods including cell viability analysis and synergy,
apoptosis cell analyses, and immunoblotting analyses. The results of cell viability50
could evaluate the interaction between cells and the treatments by survival percentage.
Cell apoptosis51, which usually combine with Western blotting52, is based on the protein
production53 (as in Figure 2.6) to predicate the expression of the gene. With all these
techniques and many others, we had a general information about how different treatments
interacted with the cells as a whole. And after all these bulk cell studies, further studies
would be conducted as in a tumor or animals.

Figure 2.6 Western blot analysis to check EMT-related gene expression. Densitometry
shows data from three experiments; the values from each experimental set were
normalized with control as related percentage (*P < 0.05, **P < 0.01, or ***P < 0.001
compared to TGF-β1 treatment alone).
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However, instead of going to larger scale, not many researchers going to the
smaller scale. The study of single cells seemed did not attract too many attentions. Single
cell studies could provide us insight into how individual cells react to the treatment. It
would help to study the real reaction mechanism and how the result agrees with the
population study including cell chemical profile researches and further more.

2.2.3

Heterogeneity of colorectal cancer

Cancer is the leading death cause for successive years which attracted many
scientists being doing research for decades. Though numerous cancer-related studies
being published every year, there were no effective methods of inhibiting the new cancer
cases and cancer death. One of the great obstacles of defeating cancer is the cell
heterogeneity. The heterogeneity of cancer cells makes the cancer study remain to be a
big challenge to understand fully cancer cells let alone get rid of them. It is even harder to
eliminate all kinds of cancer cells with one kind of treatment. All these researches
suggested the potential of dietary consumption of PMFs, especially hydroxylated PMFs,
could against lung tumorigenesis and colonic tumorigenesis.
Cell heterogeneity had attracted great interests for a long time, though some of the
researches focused on the mammalian sperm54 or endothelial lining of blood vessels55.
The others mainly focused on the heterogeneity of cancer cells. No matter which area, the
main challenge would be sorting or identifying the heterogeneous cells and purify the
cells into a specific kind. It would be easier to study just one kind at a time than the
whole heterogeneous cell population at the same time. Paulsson et al. analyzed some
studies critically and came up with an equation that could unify and extend the
20

Figure 2.7 Inter- and Intraline Variation (A) Fate profiles of DLD-1, HCT116, and
RKO cells following exposure to 0.1 mM taxol. (B) Fate profiles for A549 cells
exposed to 30 ng/ml nocoda- zole, 0.3 mM taxol, and 1 mM AZ138.

perspectives in mathematics and biology.56 It is a way to maintain the accuracy of the
study result; it is a way to correct the problems caused by the heterogeneity. Colman21

Lerner et al. studied the mechanisms of cell-cell variability and population analysis of
yeast57. It indicated that better understanding of the cell-to-cell variation mechanisms
might help narrow the heterogeneity of cellular responses to an anti-cancer study. He also
indicated that variation was mainly from pathway and protein expression instead of
expression. His study figured out two mechanisms that regulate cell-to-cell variation in
pathway capacity.
Some cancer heterogeneity studies conducted based on the DNA sequencing, as
gene transcription, in the tumor specimen. It is believed that better understanding of how
genes heterogeneous function in cell population could modulate response to stimuli
which might improve cancer healing rate58. But the sensitivity of DNA sequencing was
limited by the heterogeneity within cancer cell lines. A study conducted by Thomas et al.
came up with a micro reactor-based pyrosequencing, with this method, with a specific
DNA fragment from samples, he could detect rare cancer59. It provided patient more
targeted cancer therapies based on the accurate identification of the cell heterogeneous
cancer.
Heterogeneity in cell populations came from not only intrinsic but also extrinsic
factors. Slack et al. found out that cells heterogeneity was related to the drug's
mechanism.60 In all cases Snijder et al. analyzed and provided an explanation of the
heterogeneous cellular activities .61 The fate of cancer cells could be studied and plotted
in fate profile. 62 The result indicated that stimuli could induce heterogeneity in intra- and
interline (Figure 2.7).
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There was still some studies base on the cell morphology53,63, as showed in
Figure 2.8, the lower expression of siA1+siA2 could relate most heterogeneity and cell
morphology and western blot could help prove it. The direct observation of the cells
could provide a clear image of how the cells would change the appearance due to the
stimuli.

Figure 2.8 Impact of the treatment with siRNAs on HCT 116, HCT 116 p53-/-, and HT1080 cancer cell lines. A, 72 h after transfection, cells were harvested and processed to
determine the impact of RNAi on A1 and A2 expression. Western blot analysis was
performed with the polyclonal anti-A1/A2 antibody. B, effect of the siRNA treatments
on cell growth as measured by population doublings. The gray area indicates that cells
displayed an altered morphology reminiscent of apoptotic cells. C, phase contrast
microscopy (magnification, ×200) of cells treated with siRNAs. D, the DNA content
profile of HCT 116 p53-/- cells treated with siRNAs is shown.
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2.3 Colorectal Cancer Stem Cells
2.3.1

Introduction to Colorectal Cancer Stem Cells

There are many reasons that cancer cells are heterogeneous. A possible reason was
that the cancer cell clusters contain not only normal cancer cells but also cancer stem
cells. Increasing scientists started to believe that, like life, cancer starts from a single stem
cell. Stem cells are a kind of cells that equipped with the ability to perpetuate through
self- renewal as well as the ability to generate differentiated particular tissue cells.
Therefore, cell population became heterogeneous after culture, passage and stimuli. The
hierarchical, or cancer stem cell, predicted that tumours comprised cells with diversed
tumour growth potential and that not every cell within a tumour had equal tumour
initiation potential and only cancer stem cells are the only cells that contain long-term
self-renewal potential, a necessary prerequisite for clonal maintenance64. The stem cells,
which are not normal cancer bulk cells, required an alternative method to eliminate
(Figure 2.9). Normal anti-cancer treatment may not be able to inhibit stem cells.
Therefore, the specific study focused on stem cells is necessary and important.
The presence of leukaemia stem cells was widely discussed for years before
technological advancements proved their existence. In order to demonstrate that a tumour
is organized in a hierarchical manner, it is crucial to purify and assay the distinct cell
types functionally. Researchers figured out that when culture the cells with special media
and unattachable plates, cells could generate cell spheres. As showed in Figure 2.10A, the
spheres could be generated and after a long time of culturing the cells, the size of the
sphere would increase. And the fraction of the CSC would maintain and even increase.
We considered it to be an enrich and purify process65. After culturing and passaging the
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stem cells several passages, only the stem cell which fits the non-attachable environment
the best could remain. Most of the normal cancer cells, though might attach on the stem
cells at the first several passaging, would not be maintained in the environment and
would be eliminated in the end66. But even passaged for many passages, the cells could
maintain the stemness (Figure 2.10B).

Figure 2.9 The construction of cancer and the therapy results assumptions. Normal
cancer treatment could only decrease the number of normal cancer cells. The cells would
grow back after certain amount of time. CSC targeted therapy could decrease the number
of CSC, decrease the cancer in the long run.

There are still developing ideas about cancer stem cells, including more than one
type of stem cells, which makes the study of the stem cells even harder.
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2.3.2

Biological Studies of Colorectal Stem Cells

Stem cells though important, but rare in most tissues and cancer population as well.
It is hard, though important, to identify and sort stem cells. The process of separating
cells based on cell surface marker expression and testing the stemness function of
separated cell fractions is considered as a test for the hierarchical model. There are many
antibodies believed express differently between stem cells and normal cancer cells. Many
kinds of methods are being used to identify and isolate CSC, especially the application of
the markers (including phenotypic and functional markers). Studies always consider that
the surface markers of the cancer stem cells are different from the normal cancer cells. To
effectively sort the cancer stem cells out, unique biomarkers would be needed. Specific
markers could be found to identify and
isolate CSC had been widely accepted
(Figure 2.10). However, it was still
hard to get a combination of markers
efficient enough to purify the CSC
fraction.67 The first cell surface marker
applied to isolate colon cancer stem
67,68

cell is CD133

. Shipitsin et al. first

studied the molecular definition of
gene expression in the breast cancer

Figure 2.10 Sphere-forming prostate cells
generated and passaged in vitro. (A) Spheres
in suspension generated from single cells of
PC3, imaged on indicated day of culture. (B)
PC3 spheres could be serially passage in
vitro.

cells and suggested that targeting CD44+ cancer cells could help patients therapeutic69.
Usually, during flow sorting application, gene marker Lgr570, surface markers CD13371
and CD4472,73 were used mostly to identify human cancer stem cells prospectively.
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However, take CD133, a five-transmembrane-domain glycoprotein, as an example.
Previous studies showed controversial results. Some studies showed great evidence that
CD133+ could be an important surface marker to isolate CSC71,74, while many others
believed CD133+ was irrelevant to tumor generating75,76. While, CD44+, an adhesion
molecule that binds hyaluronate77, when combined with the epithelial cell adhesion
molecule (EpCAM), also known as epithelial-specific antigen (ESA)78 , were seemed
more robust as markers of CSC than the most reported marker CD133. The activity of
aldehyde dehydrogenase isoform 1 (ALDH1) that can be assessed by the ALDE- FLUOR
assay has also been identified as a common functional marker of CSC. In breast
carcinomas, high ALDH activity identifies the tumorigenic cell fraction, capable of selfrenewal and generating tumors that recapitulate the heterogeneity of the parental
tumour79. As believed that CD133+ cells are tumorigenic, magnetic separation was used
in study71. Label the cells with CD133/1 microbeads, in this way, the magnetic could
attract the labeled cells and complete the separation. These surface marker studies, along
with other quantitative assays, was widely considered as first purification of cancer stem
cells. However, results from the markers CD133 and the others showed the controversial
result. Some studies proved the stem cells and the surface marker CD133 or CD44 are not
related. Tumor-initiating cells could be found in both CD133+ and CD133- cell
fractions80.
Instead of trying to find the unique surface markers from the cancer stem cells,
some other studies focused on physical properties of stem cell difference. Many
researchers had been using density difference to isolate different kinds of cells including
T cells81, animal samples82 and even stem cells83. Michael Clarks’group made the first
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identification of cancer stem cells in a solid tumour was achieved in human breast
cancer84. The cancer stem cell subset could be passaged serially. Alsothe parent tumour
derived the histologically heterogeneous xenografts. In another study about separation of
bone marrow cells, Rosca et al. applied Percoll discontinuous gradient to do the
separation.85 A small cell population segregated at density 1.070 g/ml could generate
more colonies compared with total bone marrow. These cells were considered to be
containing more stem cells. Percoll which is a solution of the silica-based colloidal
medium has almost ideal property for density isolation. Percoll solution is non-toxic and
ideal ionic strength and pH, which made it great for cell separation. The size of the silica
colloidal made it impossible to penetrate into biological membranes could protect the
cells from damage. The ability to form both self-generated gradients at moderate
centrifugation force could minimize the damage to the fragile samples. After isolation
and purification, the Percoll removal procedure is easy which guaranteed the reliability of
the result.
The best application of determine the stemness of the cells is by carrying out in
vivo limiting dilution assays. The essay enables one to calculate the cancer-initiating cell
frequency in the unfractionated colon cancer cells.
Though a large number of researches had been done about cancer stem cells, the
isolation and purification of them are still not effective enough. A more reliable method
is still in need.
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2.4 Raman Microscopy
2.4.1

Introduction of Raman Scattering

Figure 2.11 The relationship between infrared, Rayleigh scattering and Raman scattering.

The inelastic scattering of light was predicted by Adolf Smekal in 1923 and first
observed in 1928. The inelastic scattering was named after one of the discoverers Sir C.
V. Raman86. The mechanism of Raman scattering is when the laser beam shoots a
sample, two kinds of scattering, namely Rayleigh scattering and Raman scattering, would
reflect back. The Rayleigh scattering is elastic scattering which means it does not change.
However, the Raman scatter is a kind of inelastic scattering as the laser light interacts
with molecular from sample and resulted in the shift of wavelength. The reflected Raman
scattering carries information of different vibrational modes of a molecule. In this way,
Raman spectroscopy offered a unique finger printing technique to characterize sample
moleducle.
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2.4.2

Introduction of Raman Spectroscopy

Raman spectroscopy is based on Raman scattering that can be used for molecular
characterizatio non-destructively and rapidly. Raman spectroscopy and Raman imaging
has been shown to be a potential candidate for non-destructive and rapid identification of
many compounds. It has been applied in many areas including archaeologically
artefacts87, drug abuse88, crime scenes89 and minerals from space mission90 to determine
the material. 91 It could also been applied in food science including measure lipid
oxidation92, evaluate microbial93, identify and quantify of food contaminants94 and so on.
It is of great importance that the non-destructive analysis ability of Raman spectroscopy
of biological samples95. One of the applications of Raman spectroscopy is to diagnose
many severe diseases96. Allograft transplantation could be the rescue for patients with
failed organs. The acute detection of allograft rejection after transplantation could be
determined (Figure 2.12).
Raman spectroscopy could also be applied on a variety of biochemical samples
including not only tissues but also single cells97. The studies determined the application
of human arteries and cancer was dominated by protein bands. And the application on
kidney and biliary calculi could determine the stones existence. On hair and nails, Raman
spectroscopy could measure metabolic disorders and drug poisoning .Also, Raman
spectroscopy could also determine the tooth dentine by the fluorescence properties of
demineralized dentine. When applying Raman spectroscopy on implants, prostheses and
foreign inclusions, it could predict their long-term performance. Furthermore, Raman
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spectroscopy could be applied in many other areas including eyes, single cells, DNA and
stratum corneum for accurate and efficient detection.

Figure 2.12 A grade 1R (mild rejection) endomyocardial biopsy sample is examined by
Raman spectroscopy (A), optical microscope (B), and histopathology (C). Raman spectra
are collected at locations marked in , B. Rejected Raman spectra (I758 > I718) and their
corresponding locations are marked in red, and the normal spectra (I758 < I718) in blue.

2.4.3

Introduction of Raman Microscopy

Microscopy is a technique using microscopes to make naked eyes to view objects
that are not within the resolution range of the normal eye. Raman microscopy is a
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technique couples with microscopy and Raman spectroscopy and has been widely applied
in the detection of the biological sample. It can provide rich biochemical information,
such as proteins, peptides, nucleic acids, glucose, lipids and cells, and has been widely
accepted as a routine analytical characterization methodology. Furthermore, Raman is
also used in the detection of diseases, including various cancers, Alzheimer’s disease, and
Parkinson’s disease.
Raman microscopy is a powerful tool, it could also help characterizing cell
samples, tissue samples98 and even live animal samples. Studies have applied Raman
microscopy on brain or kidney tissues to create a database for future diagnosis99. It could
detect tumor existence100 without sacrificing and dissection of the mice.

Figure 2.13 Raman spectra of doxorubicin-treated leukemic T cells (Jurkat T cell line),
where the cells have been treated with two different concentrations of doxorubicin as
indicated in the figure. a) Spectra for cells treated for 24 h are indicative of chromatin
condensation. b) Spectra for cells treated for 36 h are indicative of membrane blebbing.
c) Spectra for cells treated for 72 h are indicative of apoptotic body formation.

When coming to the cell sample analysis, Raman could characterize the sample
individually101. Offered us a different and detailed way to study biology samples. By
collecting the sample one spot by another, it could provide a detailed image of the cells102
with103 or without chemical tags104. Based on the peak assignment as Table 2, we could
read information from the Raman spectra.105 Combined with quartz chips, it could make
the identification of cells106, even by DNA107. .
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While applying Raman microscopy on biology study, it could be used to study the
interaction between cells, cell heterogeneity108, and even cell identification109. After
detailed information gathered, we could predict what is going on in the individual
cells110. The preparation procedure for Raman microscopy is quite simple. The cancer
cells could just grow attached to the surface of gold slides and directly got characterized
by Raman microscopy. Even if specific cells cannot grow adherent, they could also be
centrifuged and got attached to the gold slides.

2.4.4

Statistical Analysis for Raman Spectral and Images

Multivariate methods have been applied to Raman to identify the relevant spectral
features that distinguish sample classes, such as discrimination between peptide, bacterial
and viral species, and certain cancer diagnose. Principal component analysis (PCA) is a
common method used for building multivariate linear models of complex data sets using
orthogonal basis vectors called principal components (PCs). The first PC describes the
maximum amount of variance present in the spectral data set, whereas successive PCs
describe features contributing progressively smaller variance. Therefore, PCA identifies
and extracts major trends within a given spectral data set, which variables contribute most
to this difference, and whether those variables contribute in the same way (i.e. are
correlated) or independently (i.e. uncorrelated) from each other. To statistically determine
the significance of the difference between treatments from the PCA, we introduced the
one-way Analysis of Similarity (ANOSIM). ANOSIM is based on the PC score from the
PCA to compare the similarity between the treatments. The difference between
treatments could be expressed as R-value. The range of R-value is (-1, 1). An R-value >
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0.75 indicates clearly difference, R-value > 0.5 indicates difference with some
overlapping while an R-value < 0.25 indicates almost no differences, even p-value shows
significant difference. R-values below 0 suggest more similarity between groups than
within groups and therefore a problem in experiment design.
Raman microscopy could also do the Raman imaging of cells. The chemical
images are obtained from a Raman spectral image by assigning each image spot from a
set based on a pre-defined class. When collecting the sample from rows and columns of

Figure 2.14 (A) High-resolution Raman imaging of a 1:1:1 diyne-SM/DOPC/chol ternary
monolayer taken with slit-scanning Raman microscopy. The image was reconstructed
using the diyne peak intensity at 2,262 cm−1. The images consist of 412 × 400 pixels. (Scale
bar: 10 μm.) (B) Raman and fluorescence images of a 1:1:1 diyne-SM/DOPC/chol ternary
monolayer containing 0.2 mol% Bodipy-PC. Raman and fluorescence images were
obtained in the same imaging area of the same sample. Fluorescence background during
Raman imaging was suppressed by photobleaching of Bodipy-PC under 532-nm laser
exposure. (C) Line profiles of lipid rafts calculated along the dotted lines of the Raman
and fluorescence images in B (red and gray, respectively). The line profile from the
Raman image was smoothed using the moving average.

the sample and analyzed with analytical software, a Raman image could be formed. With
the image, the contribution and location of certain chemical structure of the sample could
be determined and characterized. More detailed information could be revealed.
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Raman imaging could be applied on many areas including determine the
construction of carbon nanotube networks111, crystallization of amorphous drug112 and
diagnose cancer113 . High-resolution Raman imaging could be performed to visualize the
distribution of diyne-sphingomyelin inside ternary monolayer of cell membrane (Figure
2.14) 114. Raman microscopy used in this study was slit-scanning. In this study, the
heterogeneous distribution of diyne-sphingomyelin in ordered domains. This study
proved the feasibility of applying Raman imaging on cell membrane contribution.
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Table 2 Spectral regions with nonoverlapping standard deviations for M1 and
MR1 nuclei
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CHAPTER 3.
LABEL-FREE IMAGING AND CHARACTERIZATION OF
CANCER CELL RESPONSES TO
POLYMETHOXYFLAVONES USING RAMAN
MICROSCOPY

3.1 Introduction
Cellular imaging techniques based on vibrational spectroscopy have become
powerful tools in cell biology because the molecular composition of subcellular
compartments can be visualized nondestructively and without a chemical label 115. These
properties have been highlighted when compared to electron microscopy 116 and
fluorescence microscopy that are invasive due to the necessity of fixation and the use of
dyes or biomarkers 117. Raman spectroscopy is of particularly interest for cellular imaging
due to its capacity to monitor live cells in aqueous media 118. Raman imaging could
provide the overall biochemical profile (distribution and abundance) of a single cell,
including the lipids, proteins, and nucleic acids. Differences in the biochemical profiles
are a good basis to distinguish different cells. In addition, the biochemical profile of a cell
could change in response to different environmental factors such as cytotoxic agents in a
time-dependent and/or a dose-dependent fashion. The changes in cell spectra and images
can provide characteristic and predictive information for identification, quantification and
37

discrimination of the environmental factors. This technique has been used for imaging the
distribution of subcellular components 119, differencing among cells 109,120, discriminating
different cell cycle phases 121, in vivo tumor detection 122, detection, discrimination and
quantification of toxins 123,124, evaluation of drugs effects against cancer cells 125,
characterization of cell responses to chemical and environmental stress 123.
Polymethoxyflavones (PMFs) are a group of bioactive compounds almost
exclusively found in the Citrus genus, particularly in the peels of sweet orange and
mandarin 126. They possess many valuable biological properties such as anti-allergic 127,
anti-oxidant 8, anti-inflammatory 128, anti-proliferative 129, anti-cancer 25, and antibacterial activities. 130 Nobiletin (NBT) and its monodemethylated derivative, 5demethylnobiletin (5DN) have been previously demonstrated to have anticancer activities
against Colorectal cancer cells 50,131. 5DN was more potent in growth inhibition of
Colorectal cancer cells than NBT 27. A previous study using invasive methods such as
cell cycle and apoptosis analysis demonstrated their different modes of actions 9. NBT
induced G0/G1 cell cycle arrest in HT29 cells. However, this arrest was not accompanied
by an increase in apoptosis, indicating a cytostatic effect of NBT 22,132. 5DN, on the other
hand, caused cell cycle arrest at G2/M phase in both HT29 and HCT116 cells 25.
In this study, we aimed to use Raman microscopy to characterize the cellular
responses of two colorectal cancer cell lines, HT29 and HCT116 to NBT and 5DN at
both a single cell and a population level. Live cells in culture media were directly
subjected to the Raman microscope analysis. For the first time, we investigated the
biochemical profiles of single cells in response to NBT and 5DN. Statistical analysis was
conducted to evaluate certain specific marker peaks based on a population of the cancer
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cells. The results were also correlated with the results from cell cycle analysis in these
two cell lines. This study advanced our understanding of the modes of actions of these
two bioactive compounds against cancer cells. To the best of our knowledge, it is the first
report that used Raman microscopy to characterize and compare the interactions between
human cancer cells and anticancer phytochemicals.

Figure 3.1 A: PMF formula, Nobiletin (NBT) and its metabolize 5-demethylnobiletin
(5DN). The 5DN is the hydroxyl-PMF counter part of NBT.

3.2 Materials and Methods
3.2.1

PMFs and cell lines

The isolation of NBT and the synthesis of 5DN were carried out as previously
described [1]. The stock solution of NBT was made by dissolving NBT in DMSO to yield
a concentration of 100 mM stock. The stock solution of 5DN was made by dissolving
5DN in DMSO to yield a concentration of 20 mM stock. Human colorectal cancer cells
(HT29 and HCT116) were purchased from ATCC and cultured in RPMI media
supplemented with 5% heat-inactivated FBS 100 U/mL of penicillin, and 0.1 mg/mL of
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streptomycin at 37℃ with 5% CO2 and 95% air in the 10 cm petri dishes. All cells used
were within 10 to 30 passages.

3.2.2

Cell Treatment for Raman measurement

Before Raman measurement, 10 mL (1×104 cells per mL) of cell suspension was
transferred to a new petri dish where a gold coated microscopic slide was placed and
incubated for 24 hours at 37℃ to allow cell attachment on the gold slide. The use of a
gold slide was found to greatly enhance the light scattering of the cells and minimize the
background noise. The HT29 cells were treated with NBT (100 μM) or 5DN (20 μM) for
48 hours. The HCT116 cells were treated with NBT (100 μM) or 5DN (8 μM) for 48
hours. The reason to lower the concentration of 5DN was because the HCT116 cells were
more sensitive to 5DN. At the time for Raman measurement, the petridish with the gold
slide was directly placed under the Raman microscope for analysis.

3.2.3

DXR Raman Microscope

A DXR Raman microscope (Thermo Fisher Scientific, Madison, WI) was used in
this study. This instrument facilitates 780 nm excitation and 24 mW laser power through
a 60× water immersed objective (Olympus, Japan). Aperture was set to be 50 µm slit,
grating 400 lines/mm and the spot size was 1.0 µm. Each spectrum was acquired in the
400-2000 cm-1 range. The acquisition time was 1s, repeated twice, and the spectrum was
averaged automatically by the OMINICS software (Thermo Fisher Scientific). The
working distance of the objective lens to the surface of the gold slide was kept
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consistently at 1.5mm to minimize the variance caused by the different laser penetration
depth in the cells. When collecting spectra from cells, the objective lens would immerse
into media containing petridish to keep the cells alive and attached on the gold slide.
Cells would be considered alive for detection for an hour.

For single cell imaging, we randomly selected cells within the range of 25 - 35 µm in
diameter in each treatment, to minimize the spectral variance due to the different cell
sizes. Each treatment was repeated three times independently. Raman mapping was
performed by collecting 150 spectra with (or less than) a 5 µm step size over a cell in
sequence. The images were integrated based on the Raman spectra at specific peak shifts
using the Atlµs function in the OMINICS software (Thermo Fisher Scientific). All the
spectra were put in the same common scale to compare, no other application, including
subtraction, was done.
For cell population analysis, we randomly collected at least 15 spectra from each
cell and at least 5 cells were included in the analysis. The spectral data were averaged and
further analyzed by principal component analysis using the TQ Analyst software
(Thermo Fisher Scientific). Principal component analysis (PCA) is a mathematical
procedure that uses orthogonal transformation to convert a set of observations of possibly
correlated variables into a set of values of linearly uncorrelated variables called principal
components.
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3.2.4

Data analysis

Statistics results on the numerical comparison were presented as mean ±SD in the
figures. A one-way ANOVA was used in the study. The Least Significant Difference
(LSD) test was used to determine the difference between two data sets. A 0.5%
significant level was used for all tests.
To compare spectral data between groups, a one-way ANOSIM (Analysis of
Similarity) was used in the study133. The comparison was based on 9999 permutations,
the Euclidean distance as the dissimilarity metric and the first three principle component
scores (PC1, PC2 and PC3). A 0.01% significant level was used. In ANOSIM, R value
measures the difference between two groups under comparison. The range of R-value is
(-1, 1). An R-value > 0.75 indicates clearly difference, R-value > 0.5 indicates difference
with some overlapping while an R-value < 0.25 indicates almost no differences, even pvalue shows significant difference134. R-values below 0 suggest more similarity between
groups than within groups and therefore a problem in experiment design.

3.2.5

Cell Cycle Analysis

HT29 (1×104 cells/well) and HCT116 (1×104 cells/well) cells were seeded in 6well plates. After 24 hours incubation for attachment, the HT29 cells were treated with
NBT (100 μM) or 5DN (20 μM) and the HCT116 cells were treated with NBT (100 μM)
or 5DN (8 μM). After another 24 hours, the floating cells and adherent cells, which were
detached by brief trypsinization (0.25% trypsin-EDTA; Sigma-Aldrich), were collected.
Cell pellets were washed with 1mL of ice-cold PBS and then resuspended in 1mL of 70%
ethanol in -20℃ for at least 24 hours. After centrifugation (1,600g, 1 min), the
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supernatant was removed and cells were incubated with 0.3 mL of PBS containing 30 mg
RNAse (Sigma-Aldrich) and 3 mg propidium iodide (Sigma-Aldrich) for 30 min at room
temperature. Single-cell suspension was generated by gently pipetting. Cell cycle was
analyzed using a BD LSR II cell analyzer at the analytical cytometry facility (University
of Massachusetts Amherst), and data were processed using Modifit software. Statistics
results on the numerical comparison in the figures were presented as mean ±SD. A oneway ANOVA was used in the study. The Least Significant Difference (LSD) test was
used to determine the difference between two data sets. A p<0.05 significant level was
used for all tests.

3.3 Results and discussion
3.3.1

Single cell imaging of HT 29 Cells and HCT116 Cells in responses to the
treatment with NBT and 5DN

For each treatment (control, NBT-treated, or 5DN-treated), total 15 single living
cells (around 25-35 µm in diameter) from both cell types attached on the gold slide were
randomly selected under the microscope for Raman mapping. The representative optical
images were shown in Figure 3.2. Their corresponding Raman images were showed in
Figure 3.3 and Figure 3.4. For one cell, three Raman images were obtained by integrating
over the lipid (CH2 twist) at peak 1301 cm-1, protein (Symmetric ring breathing) at peak
1005 cm-1 and the O–P–O stretching of the DNA backbone at peak 1095 cm-1. These
peaks were chosen to represent the macromolecules in cells due to the general agreement
of the peak assignments by previous studies 125. The cell images not only demonstrated
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the distribution of the biomolecules but also indicated the relative abundance of the
biomolecules.

Figure 3.2 Corresponding cellular optical images of the HT29 and HCT116 chosen for
the Raman images of control or after treated with NBT (100µM) and 5DN (20µM for
HT29 and 8µM for HCT116) for 48H.

When treating with NBT, HT29 cells and HCT116 cells showed similar results.
(Fig. 1B and Fig.4, more cell images were shown in Fig. S2), it can be observed that the
intensity of signals for the lipid, protein and nucleic acid in the treated cells were all
significantly lower than the control cells. However, very different responses were
observed from the HCT116 cells treated with 8 µM of 5DN compared to 20 µM of 5DN
treated HT29 cells. Localized higher signal of lipid was observed. The high intensity of
lipid was not found in the central region of the cells as in the control cells, but close to the
outline region of the cells. The protein signal in cells treated with 5DN decreased, but not
as much as that induced by NBT. The intensity of nucleic acid was not significantly
different between 5DN-treated cells and control cells. Furthermore, HCT116 cells were
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found to be more sensitive to 5DN than HT29 cells. Because, even at the reduced dose of
the 5DN (8 µM), the HCT116 cells had a stronger response, evidenced by the distorted
cell structure.

Figure 3.3 Raman images of the HT29 cells obtained by integrating over the CH2
twist (lipid) at peak 1301 cm-1, over Sym. Ring br Phe (protein) at peak 1005 cm-1,
and O–P–O stretching of the DNA backbone at peak 1095 cm-1

These differences clearly demonstrated the different cellular responses of cells to
NBT and 5DN. We speculated that the treatment of NBT might result in inhibition of the
DNA replication, and reduction of synthesis of cellular proteins, thus reducing the signals
of the overall macromolecules overtime. On the other hand, 5DN may interact with the
lipid and cause damage to the membrane, but may not act on nucleic acids. Draux et al
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(2011) used Raman microscopy to probe the effects of an anti-cancer drug, gemcitabine
on lung cancer cells. It was found that gemcitabine caused the decrease of nucleic acids,
which was compatible with the mode of action of the drug that was inhibition of DNA
replication and RNA synthesis.

Figure 3.4 Raman images of the HCT116 cells obtained by integrating over the CH2 twist
(lipid) at peak 1301 cm-1, over Sym. Ring br Phe (protein) at peak 1005 cm-1 and O–P–O
stretching of the DNA backbone at peak 1095 cm-1. The red spots in the HCT 116 images
were likely from the impurity on the gold slide.

Comparing the images obtained from the control cells and the cells treated with
100 µM of NBT (Figure 3.3 and Figure 3.4 and Figure 3.5 ), it can be observed that the
intensity of signals for the lipid, protein and nucleic acid in the treated cells were all
lower than that of the control cells. Very different responses were observed for the cells
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treated with 20 µM of 5DN. For example, localized higher signal for lipid was observed.
The high intensity of lipid was not found in the central region of the cells as in the control
cells, but close to the outline region of the cells. The protein signal in cells treated with
5DN decreased but not as much as that induced by NBT. No significant difference was
found in the intensity of signals from nucleic acids between 5DN-treated cells and the

Figure 3.5 Cellular optical images and corresponding Raman images of the HT29 and
HCT116 chosen for the Raman images of control (A: HT29 cells, D: HCT116 cells) or
after treated with NBT (B: 100µM for HT29 cells, E: 100µM for HCT116 cells) and 5DN
(C: 20µM for HT29 ,F: 8µM for HCT116) for 48H. Raman images cells obtained by
integrating over the CH2 twist (lipid) at peak 1301 cm-1, over Sym. Ring br Phe
(protein) at peak 1005 cm-1 and O–P–O stretching of the DNA backbone at peak 1095
cm-1. The red spots in the images were likely from the impurity on the gold slide.

control cells. These differences clearly demonstrated the different cellular responses of
the HT29 cells to NBT and 5DN. We speculated that the treatment of NBT resulted in
inhibition of the DNA replication, and reduction of synthesis of cellular proteins, thus
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reducing the signals of the overall macromolecules overtime. On the other hand, 5DN
may interact with the lipid membrane and cause damage to the membrane, but may not
act on nucleic acids. Draux et al (2011) used Raman microscopy to probe the effects of
an anti-cancer drug, gemcitabine on lung cancer cells. It was found that gemcitabine
caused the decrease of nucleic acids, which was compatible with the mode of action of

Figure 3.6 Raman intensity analysis of the Raman shift at 1301 cm-1 (lipid), 1005 cm-1
(protein), 1095 cm-1 (nucleic acids) of a population of control HT29 cells, and cells after
treatment with NBT and 5DN. A: Statistical analysis was conducted among control and
treated cells, and different notations in the bar charts indicate statistical significance. All
data represented mean ±SD (n = 75). Different characters represented a significant
difference (p < 0.05) within the same category. B: Raman spectra of the control and
treated cells, and different vertical dash lines marked different Raman shift.

the drug that was inhibition of DNA replication and RNA synthesis.
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3.3.2

Cell population analysis of HT29 Cells in responses to the treatment with
NBT and 5DN

To ensure that the observed phenomena were not specific to individual cancer
cells, we performed a population study. The intensity of the marker peaks was shown in
Figure 3.6. Basically, the results from the population study were in a good agreement
with those from the single cell study. Among the NBT treated cells, there was a
significant decrease in the intensity of lipid, protein, and nucleic acid signal compared to
the control cells. For 5DN treated cells, the intensity of the lipid signal was statistically
stronger than that from the control cells, and the variance of the lipid peak was relatively
large, indicating the distribution of the lipid signal intensity has a larger variance. There
was no statistical difference between the signal intensity of protein and nucleic acid in
5DN-treated cells and that of the control cells. The population analysis results confirmed
that the Raman image analysis from single cells was representative and the difference
observed between different images were statistically significant at the population level.

3.3.3

Cell cycle study of HT29 Cells in responses to the treatment with NBT and
5DN

Cell cycle analysis by flow cytometry was conducted on the cells treated with
NBT and 5DN. The results demonstrated that NBT and 5DN produced different effects
on the cell cycle of HT29 cells, which indicated that the two compounds may act through
different mechanisms. As shown in Figure 3.7, the cell population increased at the G0/G1
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phase after treatment with NBT. In the meantime, a significant decrease in cell
population was observed in both S phase and G2/M phases. These results suggested that
NBT caused cell cycle arrest at G0/G1 phase in the HT 29 cells. On the other hand, 5DN
caused a slight increase in the cell population at the G2/M phase, which suggests that
5DN led to G2/M phase arrest.

Figure 3.7 Cell population analysis of the HT29 cell cycle after treatments with NBT and
5DN by flow cytometry. Statistical analysis was conducted among control and treated
groups in G0/G1, S, and G2/M phases separately, and different notations in the bar
charts indicate statistical significance. All data represented mean ±SD (n = 3). Different
characters represented a significant difference (p < 0.05) within the same category.

The results from cell cycle analysis were in agreement with our speculations
based on the Raman cell imaging analysis. In the G0/G1 phase, cells are growing and
preparing for the DNA replication. In the S phase, the DNA replication occurs, which
will result in the significant increase of the DNA content. In the G2/M phase, the cells
divide into two daughter cells118,135. NBT treatment arrested the cell at G0/G1 phase, and
NBT-treated cells have difficulty to enter the S phase. This may be caused by inhibition
of DNA replication. Over time, this may lead to a decrease of the cellular protein and
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lipid content. 5DN led to the G2/M phase cell cycle arrest, which supported the
speculation that the 5DN may cause damage in the lipid membrane so that the cell
division interfered.

Figure 3.8 Raman intensity analysis of the Raman shift at 1301 cm-1 (lipid), 1005 cm-1
(protein), 1095 cm-1 (nucleic acids) of a population of control HCT 116 cells, and cells
after treated with NBT and 5DN. A: Statistical analysis was conducted among control
and treated cells, and different notations in the bar charts indicate statistical
significance. All data represented mean ±SD (n = 75). Different characters represented
a significant difference (p < 0.05) within the same category. B: Raman spectra of the
control and treated cells, and different vertical dash lines marked different Raman
shift.
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3.3.4

Raman and cell cycle study of HCT116 cells treated by NBT and 5DN

The similar experiment was conducted on the HCT116 cells. NBT induced the
similar cellular response of HCT116 cells compared with the HT29 cells, where the
overall signal intensity of lipid, protein, and nucleic acid were all reduced (Figure 3.4).
The HCT116 cells were found to be more sensitive to 5DN. For example, even at the
reduced dose of the 5DN (8 µM), the HCT116 cells had a stronger response, evidenced
by the distorted cell structure. Similar to the HT29 cells, the lipid intensity of the 5DNtreated HCT116 cells were much higher than that of the control cells, and no difference
was observed in the nucleic acid signal intensity between 5DN-treated cells and the
control. However, the protein intensity of 5DN-treated cells was lower than that of the
control cells. At the population level (Figure 3.8), the results further demonstrated the
difference observed in the single cell imaging was meaningful. Flow cytometry analysis
of the HCT116 cells showed the similar trends as the HT29 cells. The cell population
increased at the G0/G1 phase after treatment with NBT, which indicates the NBT caused
cell cycle arrest at G0/G1 phase. In contrast, 5DN treatment resulted in G2/M phase
arrest in HCT116 cells, and the extent of the cell cycle arrest in HCT116 cells was
stronger than that of 5DN-treated HT29 cells. These results again demonstrated that
HCT116 cells were more sensitive to 5DN compared with the HT29 cells. The cell cycle
data (Figure 3.9) well supported the cell image data. The significant cell arrest at the
G2/M phase caused by 5DN supported the speculation that 5DN at this concentration
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may cause damage to the cell membrane that in turn may interfere cell division during the
G2/M phase.

Figure 3.9 Cell population analysis of the HCT116 cell cycle after treatments with NBT
and 5DN by flow cytometry. Statistical analysis was conducted among control and treated
groups in G0/G1, S, and G2/M phases separately, and different notations in the bar charts
indicate statistical significance. All data represented mean ±SD (n = 3). Different
characters represented a significant difference (p < 0.05) within the same category.

3.3.5

PCA analysis of the cellular responses of HT29 and HCT116 cells

PCA is a common method for analyzing the overall spectral variance of the
Raman data. Generally speaking, if there is no overlapping between the data cluster, then
it means the spectra are significantly different from each other. In the PCA plot (Figure
3.10), the control cell data clusters for HT29 and HCT116 were separated, which means
the spectral characteristics of these two cells were different due to its different
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biochemical profiles. After treatment with NBT, the data clusters of treated cells were
both separated from the control cells, indicating a significant difference in the overall
spectral characteristics after the treatments. The distance of the two data clusters can be
relative compared. The difference between the HCT116 control data cluster and the
treated data cluster was greater than that of the HT29 cells. It demonstrated that the

Figure 3.10 The 3D PCA plot of the control HT29 and HCT116 cells and treated with
NBT 100 μM for 48h and the ANOSIM result based on the PCA plot. PC 1 explained
71.64% of the total data variance and the PC 2 explained 8.83% of the total data
variance and the p-value< 0.01%

HCT116 cells showed stronger cellular responses to the treatment with NBT than the
HT29 cells.
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From ANOSIM result, R-value between HT29 and HCT116 control cells is
0.07117 which is <0.25, indicated a slight difference between the two kinds of cancer
cells. The PCA result showed the similar result -- the PC1-PC2 dimension (Figure 3.10)
showed the control cell data clusters of HT29 and HCT116 were mostly overlapped,
while in the PC1-PC3 dimension (Figure 3.11) the control cell clusters were set apart.
This indicated the spectral characteristics of these two cells were similar to each other in
general with a slight difference. After being treated with NBT for 48H, compared to the
corresponding control samples, both HT29(R=0.2819) and HCT116(R= 0.2871) cells
were induced difference. The PCA plot agrees with the ANOSIM result but the PCA plot
also shows the HCT116 cells cluster and the HT29 cells moved towards different

Figure 3.11The 3D PCA plot of the control HT29 and HCT116 cells and treated with
NBT 100 μM for 48h. PC 1 explained 71.64% of the total data variance and the PC 3
explained 2.56% of the total data variance.

direction along the PC1 axis. Both PCA plot and ANOSIM result reflected the difference
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between the two colon cancer cells in response to the same treatments. This also
validated the result of the Raman image study and the cell cycle study.

3.4 Conclusions
In conclusion, we utilized Raman microscopy to noninvasively characterize and
compare two types of colorectal cancer cells responding to the treatments with two PMFs
(i.e. NBT and 5DN). By evaluating at both single cell and cell population levels, we
found that NBT induced more change in the nucleic acid peak intensity in the cell spectra
in comparison with 5DN, while 5DN induced more changes in the localized lipid peak
intensity than NBT, indicating the different modes of actions of these two PMFs against
colorectal cancer cells. Supported by the results of the flow cytometry study, our data
suggested that NBT may interfere DNA synthesis, while 5DN may alter the cellular
lipids. HCT116 cells were more sensitive to both PMFs than HT29 cells. Overall, this
study advanced our understanding of the modes of inhibitory actions of NBT and 5DN
against human colorectal cancer cells. This study also demonstrated the feasibility of
using Raman microscopy to label-free image and characterize cancer cell responses to
anticancer agents, which could be extended to study other cell-drug interactions.
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CHAPTER 4.
CHARACTERIZING HETEROGENEOUS CELLULAR
RESPONSES TO POLYMETHOXYFLAVONES USING
RAMAN MICROSCOPY

4.1 Introduction
Nowadays, most of the approaches focusing on anti-cancer drugs were based on the
population study and data collected by population averaged methods including MTT
assay, cell cycle analysis, cell apoptosis analysis etc. 136 The population study could
provide average information about the cellular responses to the perturbations. However,
the cells away from the average still occupied eminent portion.137 The heterogeneity
would always be considered as noise56, intrinsic noise due to the random difference from
cellular individual molecules, and extrinsic noise due to environment fluctuations61. The
misapplication of ignorant the minority cells might result in the unreliable prediction.138
What if the aspects we ignored was the real reason of the varieties?139 Besides, many
studies confirmed the significant heterogeneous within cancer cell population.140 The
whole population distribution is crucial to the final result. Due to the difference between
the cells, variety cellular responses and functional differences were induced. Various
studies were focused on the heterogeneity already, which made it important to detect the
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heterogeneity of the cancer cells before and after each study. The heterogeneity
determination could help decide when the variation could not be neglected.
The detection of heterogeneity was mostly at a high resolution of single cells. The
difference could be verified from cell composition. Some cell heterogeneity study had
been done in some specific areas like mammalian fertility54, skeletal muscle
heterogeneity141 and preimplantation embryo development.142 Many techniques had been
applied on characterizing the cells like ﬂuoresce labeled image143,144, and many others
including combine other techniques like protein concentration determination, subcellular
protein fractionation or western blot145. All these techniques are mainly focused on the
protein changes which always generated by DNA change69. The lipid change and cell
structure146 change had also been studied as the signal of the diversity147. It is important
to take all the aspects into consideration. However, all the current methods required
complicated chemical analysis methods.
Raman spectroscopy is a fast developing instrument and gaining more and more
attention from diverse fields, including diagnosis148 of tumor and cell image149. The
spectra provided by Raman spectroscopy could tell the details about how cells interact
with the drugs149, and how much damaged caused by the drugs150. The difference in cell
structure between control cells and treated cells would be easy to be recognized using
Raman spectroscopy.
The treatments we applied in this study were nobiletin and 5DN. Nobiletin is
considered one of the most abundant flavonoids in the citrus genus and ubiquitous in
citrus peels with large percentage content151. There are tremendous scientific findings and
evidence supported its biological activities including inhibition of inflammation, anti58

cancer, and prevention of metabolic syndrome25,152 etc. Nobiletin’s biotransformation
plays a major role in the biological effects and has been studied extensively recently. One
of the nobiletin’s major metabolites was 5DN.21 Nobiletin and its metabolites 5DN have
great potential to become efficacious therapeutics for human diseases. After treated with
nobiletin or 5DN, some cells would be floating from the original attached to the petridish state. Due to the fact they were already distinctive from the attached cells, these
floating cells were collected and studied separately.
Our study provided an innovative and fast method to verify the heterogeneity of the
cell lines after the treatment. The straightforward result made it clear why and how the
treatment altered the cells. It could provide researchers with a big picture of how the
heterogeneity was induced.

4.2 Materials and Methods
4.2.1

PMFs and cell lines

The isolation of nobiletin (NBT) and the synthesis of 5DN were described
previously.9 Briefly, the stock solution of nobiletin was carried out by dissolving high
concentration nobiletin in DMSO to yield a concentration of 100mM. The stock solution
of 5DN was made by dissolving high concentrated 5DN in DMSO to yield a
concentration of 20mM. Human colorectal cancer cells HT29 was purchased from ATCC
and cultured in RPMI media supplemented with 5% heat-inactivated FBS 100 U/mL of
penicillin, and 0.1 mg/mL of streptomycin at 37℃ with 5% CO2 and 95% air in the 10cm
petri dishes. All cells used fell within 10 to 30 passages.
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4.2.2

Cell Treatment for Raman measurement

Before Raman measurement, 2 mL (1×104 cells per mL) of cell suspension was
transferred to a new 6-well petri dish and incubated for 48 hours at 37℃. The cells were
treated with NBT (100 μM) or 5DN (20 μM) for 24hours, 48 hours and 72 hours. By
collecting the media, which contains the floating cells, would be treated as the floating
sample. Trypsin down the attached cells and collect as the attached sample. Centrifuge
the samples separately on the gold slides, contained in a 6-well petri dish at the speed of
2×104 g for 25 minutes. The usage of the gold slide was found to greatly enhance the
light scattering of the cells and minimize the background noise. Fix the cells with 10%
formalin overnight. At the time for Raman measurement, the petri dish with the gold slide
was placed under the Raman microscope for analysis. For each floating cells, we used 10
replicates to average a single spectrum and 5 for the attached cells. And each replicate
was generated from at least 10 spots from a single cell.

4.2.3

DXR Raman Microscope

A DXR Raman microscope (Thermo Fisher Scientific, Madison, WI) was utilized in
this study. This instrument facilitates 780nm excitation and 24 mW laser power through a
50× objective (Olympus, Japan). Aperture was set to be 50 µm slit, grating 400 lines/mm
and the spot size was 1.0 µm. The collect exposure time was 1.0 s and the sample
exposure was 2.0s. The working distance of the objective lens to the surface of the gold
slide was kept consistently at 1.5mm to minimize the variance caused by the different
laser penetration depth in the cells.
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4.2.4

Data analysis

The spectra data were further analyzed by principal component analysis using the TQ
analyst software (Thermo Fisher Scientific). The spectral data were further analyzed by
principal component analysis using the TQ analyst software (Thermo Fisher Scientific).
Principal component analysis (PCA) is a mathematical procedure that uses orthogonal
transformation to convert a set of observations of possibly correlated variables into a set
of values of linearly uncorrelated variables called principal components.
Statistics results on the numerical comparison in the figures were presented as mean
±SD. Analysis of variance model was utilized to compare the differences between two
data sets were determined by Student’s t-test. A 1% significant level was used in all tests.
To compare the similarity of spectra between groups in PCA, a one-way ANOSIM
(Analysis of Similarity) was used in the study. The operation was based on 9999
permutations, the Euclidean distance as dissimilarity metric and first three principle
component scores (PC1, PC2 and PC3). A 0.01% significant level was used. In
ANOSIM, R value represents the difference between two involved groups. The range of
R-value is (-1, 1). An R-value > 0.75 indicates clearly difference, R-value > 0.5 indicates
difference with some overlapping while an R-value < 0.25 indicates almost no
differences, even p-value shows significant difference. R-value below 0 suggest more
similarity between groups than within groups, therefore a problem in experiment design.
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4.3 Results and Discussion
4.3.1

Characterization of the heterogeneity of attached and floating cells

When culture cancer cells, normally cells will grow attached on the surface of the
petri dish. The cells floating in the media were always considered to be dead cells. Not

Figure 4.1A: A: Spectra and B: PCA score 3D display of both floating and attached cells
treated with NBT (100µM) under 72H treatment. C: Spectra and D: PCA score 3D
display of the attached cells treated with NBT (100µM) under 72H treatment. The
floating cells are not as overlapped as attached cells, indicate more heterogeneous than
the attached cells. The heterogeneity of the floating cells came from Raman peak shift
between 1050-1150cm-1 and 1250-1350cm-1.

many studies focused on the floating cells previously. However, when we collected the
floating cells for further Raman analysis, specific result discovered. The Raman spectra
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of the 10 different floating cells showed spectral differences from each other, mainly
from range 1000 to 1400, which most peaks represent the protein (1003cm-1 Phe sym ring
br; 1032cm-1 C–H Phe; 1230cm-1 -1267cm-1Amide III and 1340cm-1CH def)(Figure
4.1A, C). In contrast, the Raman spectra of NBT 72H attached cells are very similar to
each other. (Figure 4.1) The Raman spectra of each individual cell reflected the overall
biochemical information of the specific cell. PCA plots were used to statistically study
the difference among every single cell. As showed in (Figure 4.1B, D) data cluster of
each individual floating cells are mostly separated from each other. While the data
clusters of attached cells are mostly overlapped, which means they are not statistically
different.
This finding demonstrated that under the same treatment, the heterogeneity of
attached and floating cells is different. The floating cells are more heterogeneous than the
attached cells in the range for protein peaks. The attached cells showed less
heterogeneous between different cells under the same treatment, which showed
homogeneity of the cellular responses. It is reported that protein fibronectin is mainly
responsible for attachment153. In an earlier work154, it showed that certain kind of
heterogeneity can reveal functional differences among cellular populations against
different drug sensitivity. Our study showed that the variability among the same
treatment should also be taken into consideration.

63

The similar results between attached and floating cells were observed for all the
treatments. When combining the data points of attached and floating cells together, it is
clear to notice that the data clusters of the floating cells are always larger than the
attached cells (Figure 4.2).

Figure 4.2 PCA scores of the difference between attached and floating cells of the two
treatments NBT (100µM) and 5DN(20µM) from different time spot, 24H, 48H and 72H.

In addition to that, we observed an interesting trend that the overall difference
between attached and floating cells is decreasing along with increasing treatment time.
As in Figure 4.2, both cells treated by NBT and 5DN for 24H, the PCA score of floating
and attached plots overlapped the least. While there is still difference under both
treatments. The plots got more overlapped under the time 48H and even more at the 72H.
The R values agree with the PCA results. For NBT treated cells, after 24H treatment, R
value is bigger than 0.25 suggested a significant difference between attached and floating
cells. After 48H and 72H treatments, R value is smaller than 0.25, and the R value from
72H is even smaller than the R value from 48H. The trend of the cells under 5DN was
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similar to the NBT with slight time difference. It still showed the biggest difference for
24H, but the difference for 48H and 72H was not as significant as the NBT treated. After
72H, the attached cells were almost totally overlapped with the floating cells, and it
proved that the difference between floating cells and attached cells became less when the
treatment time increased. R-value of 5DN treated proved the same with the PCA score.
For cells treated with 5DN for 24H, R-value is already smaller than 0.25 while p<0.01,
indicates there is a difference but not so significant. After 48H and 72H, p>0.01, showed
there is no difference between attached and floating cells. The results indicated that the
treatments minimized the difference between floating and attached cells, it might due to
the severe damage had been done on the cells after certain length of time.. Meanwhile,
the spots cluster of the floating cells was consistently larger than the attached cell,
confirming the heterogeneity of the floating cells was always larger than the attached
cells.
4.3.2

The effect of treatment time on cell heterogeneity

To better illustrate the time effect to the cells under treatment, we compared the
spectra of the floating cells and attached cells separately in Figure 4.3, both attached and
floating cells got intensity increased under both treatments along with time increasing. As
showed in the spectra, for both treatment on attached and floating cells, the spectra
intensity increased along with increased time and the intensity of floating cells got
increased more than the attached cells. The attached cell treated by NBT from all three
time spots, always have the higher intensity than the floating cells. On the contrary, to the
5DN treated cells, the intensity of the floating cells treated for 72H increased higher to
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Figure 4.3Raman Spectra and PCA scores of the variances along with the time of the 2
treatments of NBT (100µM) and 5DN (20µM) from different time spot, 24H, 48H and
72H.

overcome the attached cells. Furthermore, 5DN did not induce the pattern change as
66

much as the NBT treated, but more intensity difference.
Figure 4.3 also showed that the PCA score changed along with the increasing
treatment time. There is always a greater difference between 24H and 72H, compared to
the 24H with the 48H or the 48H with the 72H. R value from the PCA scores still in
agreement with the PCA plot data. The R values between 24H and 72H from all
treatments are always bigger than the other R values. The clusters changing tendency
indicated the cell information varied based on time. Besides, the attached cells were more
dissimilar after 24H, indicating cells were more heterogeneous at first. The reason might
because the less durable cells would be altered the earliest, and the durable cells could
maintained the attachment ability to last longer. Therefore, after a certain amount of time,
durable cells remain attached, and the fragile cells got floated. Plots of the floating cells
after 72H got larger area confirming the heterogeneity of the floating cells is increasing.

4.3.3

The effect of PMF types on cell heterogeneity

The last but the most important thing is the study of the cell heterogeneity caused by
the different treatments. In Figure 4.4, we compared the NBT and 5DN treated cells at the
similar inhibition rate to control cells after 24H and 72H to study the trend. Then we
compared the different treatments in the PCA plot. The PCA score showed that the spot
clusters of the two treatments moved into different directions, confirming the different
cellular responses in both floating and attached cells. Furthermore, for the attached cells
treated after 24H, both PCA score and R value confirmed no significant difference
between the two treatments and control cells. But for the 72H attached cells, the
difference between treated cells and control cells became significant. On the other hand,
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the difference from floating cells did not increase with the increase of the treatment time.

Figure 4.4 Raman spectra of the attached and floating HT29 cells at 72H under
NBT(100µM), 5DN(20µM) and control.
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In another word, when comparing the difference between treatment times, the difference
of floating cells between 24H and 72H is smaller compared to the attached cells. It might
indicate that the treatments could cause the cells status change and the interaction
mechanism might be different.
This result got studied and proved by an earlier project. Also, it indicated that the
cells got floated might because similar chemical changes induced. In this way, the cells
would not change the chemical profile much after longer treatment time, because the
damage had already been done. Our results proved the different protein profile would
cause distinguish cellular responses and it could be greatly affected by the different
drugs. The result proved the feasibility of our previous single cell image study. In that
previous project regarding the interactions between treatments and cell chemical profile,
the cells were treated with PMFs and characterized by Raman microscopy. The concern
was mainly about the reliability of the small amount of cells selected and imaged to
predict the reaction of the whole population. This study suggested the homogeneity of the
attached cells before and after treatment, indicates the amount of cells selected possess
the potential to represent the cell population.

4.4 Conclusion
There are differences between attached cells and floating cells, as the floating cells
are more sensitive to the treatments, especially to NBT after 72H. Cancer cells though
always considered heterogeneous, the untreated, intact and adherent cells could have
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similar chemical profiles to each other. Different treatments induced difference to both
floating and attached cells, especially to the attached cells.
The result showed that Raman spectroscopy could tell the difference between
discrete treatments, time and cell conditions. It is very prominent and useful to see how
different the cells became after the treatment. The trend was clear enough itself to show
the effectiveness of the drugs or not. Besides, it proved that Raman spectroscopy could
tell the difference between floating cells and attached cells as well as different treatments
and different treatment time.
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CHAPTER 5.
CHARACTERIZATION COLORECTAL CANCER STEM
CELLS USING RAMAN MICROSCOPY

5.1 Introduction
Cancer stem cell (CSC), which had been isolated from variety kinds of tumors are
basically defined by two functional properties155: first, the potential to multipotent, which
could differentiate into cancer cells; second, ability to self-renewal, which made them
perpetuating themselves after an extended time period. The multipotent potential made
the developed anti-cancer treatments hard to have the uniform killing ability to even the
same cell line. With all these properties, CSC ensure that the cell population is
maintained or expanded for long-term clonal growth. Therefore it is important to
eliminate CSC directly to make sure they would not grow back.
Therefore, more and more studies focused on killing or inhibiting the growth of
CSC. Despite the significant increasing attentions in the field of CSC, the identification,
isolation and characterization of the CSC still remained unclear155. The normal in vitro
way to get the CSC for research would be growing the normal colorectal cancer cell in
the serum-free media and non-attachable petri dish156. In this way, only the CSC and the
normal cells which could reversibly transit back to stem state could survive. The absence
of serum and the attachable surface made the normal cancer cells lost the essential
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nutrition and environment to reproduce. The stem cells would remain after a period of
time.
To prove the cells remained in the environment to be the CSC and they are
different from normal cells, a sorting cell process with Flow Cytometry would be always
conducted. With the specific markers, researchers could deeply understand the CSC and
the sorting process would provide more pure CSC for further study157. Gene marker Lgr5,
surface markers CD133 and CD44 are the most applied markers that had been used for
flow cytometry sorting application158,159. However, it was still hard to prove that any of
these markers could really isolate and purify the CSC. Previous studies showed
controversial results about all the markers, so the combination of the markers is
required160. Therefore, the non-reliable results might suggest the utilization of the Flow
cytometry and surface markers is not sensitive enough for the CSC study. A more reliable
method is required and the key difference between normal cells and CSC is still
indistinct.
Another way to isolate different kinds of cells is to sort the cells by their different
physical property. Percoll solution is a silica-based colloidal medium has been proved
possess the property of non-toxic, ideal ionic strength and PH for cell separation.
Previous studies83 applied the Percoll solution to isolate the stem cells from the animal
samples proved its feasibility of being applied on CSC isolation.
Raman studying though had a short history but with the rapid developing speed,
made it became a reliable and widely used technique161. It had been used in many areas
including geology162, environment163 and many others164,165. The spectra and images
provided by Raman spectroscopy could tell the details about how the cells interact with
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the drugs166, and how much damaged caused by the drugs. Being a label-free, efficient,
reliable and advanced technique, the difference in cell structure between normal cancer
cells and the CSC would be easy to be recognized using Raman spectroscopy. The
efficiency of Raman spectroscopy allowed a large number of cells to be analyzed and
ensured the accuracy of the result.
In this study, we aimed to isolate the CSC by their density difference to the
normal cancer cells and identify them by Raman microscopy. The result proved the
existence of difference from density and chemical profile between CSC and normal
cancer cells. The density difference between CSC and normal cancer cells had not been
proved in vitro and the chemical profile captured by Raman microscopy is also the first
time.

5.2 Material and Methods
5.2.1

Cell Culture

HCT116 cells were cultured (1×104 cells/ml) in RPMI media supplemented with
5% heat-inactivated FBS 100 U/mL of penicillin, and 0.1 mg/mL of streptomycin at 37℃
with 5% CO2 and 95% air on the gold covered slides. All cells used were within 3 to 30
passages.

5.2.2

Cell Sorting in Continuous Gradient Solution

Culture the HTC116 cells in DMEM/F-12 media to 6-well unattachable plate in
the same incubator for 5 days to form cell spheres at 37℃ with 5% CO2 and 95% air.
Trypsin and filter the cells into single cells for further analysis.
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As demonstrated in Figure 5.1, dilute the percoll solution with nine part of percoll
and one part of 1.5N NaCl solution to make SIP solution. For the discontinuous gradient
Percoll solution, we picked density 1.02, 1.04, 1.06 and 1.08. Layer the density fixed
Percoll solution into 15ml centrifugation tube from the bottom to the upper layer at the
sequence higher density to lowest. After layer the Percoll solution, put the cells on top.
Each layer contained 2ml. Centrifuge the tube for 20,000g in swing bucket. Collect the
cells from each layer after centrifugation.
For Percoll continuous gradient, dilute the SIP solution with 0.15N NaCl solution
to make 40% SIP working solution. Centrifuge the 40% SIP solution 6ml per tube with
30,000g for 30min in an angle fixed rotor to form a continuous gradient solution. For an
advanced continuous gradient solution, centrifuge the 20% SIP solution with 30,000g for
30min.
Add 1ml 20×103 cluster cells and bulk cells into each tube. Sort the cells in
Percoll continuous gradients in swing bucket with 400g for 15min. Collect the cells from

Figure 5.1 Methods Process for Continuous Gradient
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4 density layers, wash the cells twice with 5 parts 0.9% saline water and centrifuge in
swing bucket with 200g for 5min.
Put the sorted and washed cells into gold slide containing 6-well plate. Centrifuge
the 6-well plate with 2000g in swing bucket for 20min to attach the cells on the gold
slides.

5.2.3

Raman Microscopy

A DXR Raman microscope (Thermo Fisher Scientific, Madison, WI) was utilized
in this study. This instrument facilitates 780nm excitation and 24 mW laser power
through a 50× objective (Olympus, Japan). Aperture was set to be 50 µm slit, grating 400
lines/mm and the spot size was 1.0 µm. The collect exposure time was 1.0 s and the
sample exposure was 2.0s. The working distance of the objective lens to the surface of
the gold slide was kept consistently at 1.5mm to minimize the variance caused by the
different laser penetration depth in the cells.

5.2.4

ELDA analysis

Dilute the sorted and washed cells to make 100cells/well, 10cells/well and
1cells/well. Culture the cells into 96-well unattached plates for ELDA analysis. Incubate
the cells for 2week at 37°C in a 5% CO2 incubator. Score the plates for the presence of
cell clusters. The estimated cells/well were calculated by the frequency of proliferated
cells.
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5.2.5

Data analysis

The spectra data were further analyzed by principal component analysis using the
TQ analyst software (Thermo Fisher Scientific). The spectral data were further analyzed
by principal component analysis using the TQ analyst software (Thermo Fisher
Scientific). Principal component analysis (PCA) is a mathematical procedure that uses
orthogonal transformation to convert a set of observations of possibly correlated variables
into a set of values of linearly uncorrelated variables called principal components.
ELDA analysis has been done online using the Bioinformatics facility of The
Walter & Eliza Hall Institute of Medical Research (Melbourne, Australia) (accessed at
http://bioinf.wehi.edu.au/software/limdil/index.html).
Statistics results on the numerical comparison in the figures were presented as
mean ±SD. Analysis of variance model was utilized to compare the differences between
two data sets were determined by Student’s t-test. A 1% significant level was used in all
tests.

5.3 Results and Discussion
5.3.1

Raman Microscopic Characterization of Attached and Sphere Cells

After centrifugation, the cells would attach on the gold slides. Then we fixed the
cells on the gold slide overnight for further Raman analysis with formalin. In this way,
the cells chemical profile could be fixed and protected. Then we characterized both the
sphere cells and normal cells with Raman microscopy. Unexpectedly, sphere cells
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showed a great difference at peak 1049cm-1 (Figure 5.2). The intensity of the peak could
be 50%, sometimes 6 times, higher than the normal cancer cells.

Figure 5.2 Raman spectra of PBS control, cell media control, stem cell media control,
normal cell and CSC. The Raman spectra of CSC showed a distinct peak at 1049cm-1
with a high intensity around 2000 but the others do not contain that peak.

Then we did the statistical analysis about the intensity of the peak 1049 cm-1
based on the 100 cells each. As showed in Figure 5.2, though the stem-like cells got
extruded heterogeneity, the peak intensity was much higher in stem-like cells. However,
after further analysis, we found out that not all cells from the cell clusters could induce
that peak. Only cells from the right corner of the gold slides could show that great
difference at the certain peak. Since the cells were attached to the gold slide through
centrifugation, there is highly possibility that the location difference might result from
cell density.
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5.3.2

Characterize Cells from Different Density Layers

Based on these results and assumption that the cells from the different location
from the centrifuged gold slides possess different chemical profile, we conducted the
discontinuous gradient study to sort the cells by cell density. The density range we picked
was from 1.02-1.08 compared to water.

Figure 5.3 Special spectra count in 50 cells from different layers of the cells spheres
after gradient centrifugation. The cell number from the layer 1 doesn’t reach 50 and the
layer 4 and layer 5 doesn’t contain any cells.

Figure 5.1 and Figure 5.4 demonstrated the exact cell layers in the gradient
solution. The cells from the clusters formed one cell layer at the second part while the
normal cancer cells formed one cell layer in the fourth part. We extracted each layer from
the centrifuge tube and attached the cells on the gold slides to get the cells characterized
by Raman microscopy. As showed in Figure 5.3, for the stem-like cells, we found out
that the fourth and fifth layer did not contain enough cells attached on the gold slides.
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Though the first layer contained around 5 cells, the comparison to the others failed.
Between the second and the third layer, the cells from the second layer could generate
more special peak contained spectra.
To confirm the existence of the specific peak, population study was conducted.

Figure 5.4 A: The optical images of the cells sorted by Percoll continuous solution. The
CSC formed the cell layer at an upper layer while the normal cancer cell formed the layer
at the lower layer. The tube containing both CSC and normal cancer cell formed an
extended cell layer.
B: 40% Percoll solution formed the continuous density layers ranged from 1.02-1.08g/ml.
While the 20% Percoll solution formed the continuous density layer ranged smaller than
1.02g/ml. Density beads were used as markers in the solution.

We picked 50 cells each from the forth layer of normal cancer cells and second layer of
sphere cells to record the peak intensity (Figure 5.5). The peak intensity of 1049cm-1
from CSC is much higher than the normal cancer cell confirmed the general existence of
the peak.
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Figure 5.5 Statistical analysis of the peak 1049 cm-1 intensity. The intensity from stem
cells was much higher than the same peak from the normal cancer cells. The average
intensity showed significant difference between normal cancer cell and cell sphere. The A
one way Student’s t-test was used to assess the statistical significance and p-value of<0.05
was considered statistically significant.

The results showed that the density of sphere cell is lower than the normal cancer
cell and sphere cells contained the most specific peak. It indicated that when cells treated
in the non-attachable petri dish with stem cell media, the cell clusters formed. In the cell
clusters, the density of the cells decreased. Furthermore, the decreased density cells
contained the most cells possess the peak 1049cm-1 which should contain specific
content.
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5.3.3

ELDA Study of Cells from Different Layers

ELDA study is suitable for all kinds of limiting dilution problem and it is
especially suitable for analyzing limiting dilution data arising in stem cell research. The
cells from the layer 4 and layer 5 did not reach the number requirement of the analysis,
only the first three layers could perform the ELDA study. As showed in Figure 5.6, the
cells from the sphere clusters showed around 15% of CSC while the normal bulk cells
showed around 2% of CSC. After continuous gradient cell sortation, CSC from the

Figure 5.6 ELDA of the cells from different layers. Bulk cells contained least stem cells
and followed by cells from spheres which considered to be stem cells. Stem Layer 2
represents the second layer of cells from cell spheres gradient centrifugation. After
second centrifugation of Stem Layer 2, cells from layer 3, 4 and 5 labeled Stem Layer 2-3,
2-4 and 2-5.Stem Layer 2-5 contained most stem cells.

second layer increased to reach around 27%. The cells from the second layer could
generate the most cell spheres. The more spheres the cells could generate means the more
stem cell contained. In this way, it proved that the cells from the second layer had a high
possibility that contained the most stem cells.
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Next step, we zoomed in the Percoll continuous gradient, to sort the cells from the
second layer to be more narrow density range. In this way, we could further purify the
stem cells. More purification we could conduct, more accurate the result of the study we
could access. The 20% Percoll continuous gradient solution conducted in the study to get
the cells more purified. After the second continuous gradient purification, the cells
gathered the most at the three lower layers. The third and fourth layer from the second
purification still contained around 27% CSC which is almost the same as before.
However, the cells from the fifth layer contained around 50% of CSC. The result showed
that the two purification procedure did purify the CSC cells (Figure 5.6).
After purification, ELDA would be necessary for the stem cells to test the
stemness and the stem cells percentage in the whole cell population. With ELDA data,
the effectiveness of stem cell isolation and purification could be calculated. Guided by
the result of the stem cell containing, the following research procedures would be more
specific and statistical.

5.4 Discussion
Based on the up to date research, we believe that the density of the cells from cell
sphere was different from normal cancer cells. Cells from cell spheres could be sorted by
Percoll continuous gradient. Also, cells from cell spheres had more percentage of spectra
contained high-intensity Raman peak 1049 cm-1, while normal cancer cells showed much
lower intensity. Cells with specified density from spheres could generate even more cell
spheres and had more possibilities of containing peak 1049 cm-1. Furthermore, ELDA
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data also supported the cell density study could sort the cells with different sphere
generation ability. In conclusion, we developed a method to isolate and purify CSC from
normal cancer cells and proved that Raman microscopy could detect the difference
between a normal cancer cell and CSC.
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CHAPTER 6.
OVERALL CONCLUSION AND FUTURE WORK

6.1 Conclusions
In conclusion, we demonstrated feasibility of the Raman microscopy to
characterize cancer cells in response to two bioactive compounds. The Raman image of a
single cancer cell reflects the distribution and content of major cellular biochemical,
including lipids, proteins, and nucleic acids. The changes of these components in the
Raman image can be used to study the mode of action of the treatment. In this study, we
found NBT induced more changes in the nucleic acid peaks and protein peaks, while
5DN induced more changes in the localized lipid peaks. In addition, we applied Raman
microscopic spectra and PCA analysis to study the heterogeneity of cancer cells, when
they were attached or floating in the media and their response to NBT and 5DN over
time. The floating cells show more heterogeneity when compared to the attached cells,
although the difference between the floating cells and attached cells became smaller
when treated with NBT and 5DN over time. Lastly, we explored the potential of Raman
microscopy to differentiate between CSC and normal cancer cells. An interesting peak at
around 1049 cm-1 was observed in nearly 70% of CSC enriched cells, but not in the
normal cancer cells. The origin of this peak is unknown and future study is needed to
verify the accuracy of using this peak as a CSC biomarker using Raman microscopy.
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6.2 Future Study
In future study, we will further work on the verification the 1049 cm-1 peak as the
biomarker for CSC using Raman microscopy. Enriched CSC cells from density study and
tumor study will be used to check the percentage of the 1049 cm-1 in the cell population.
In addition, we will identify the source of the peak 1049cm-1 by extracting the major
components (lipids, proteins, nulceic acids) from enriched CSC, respectively, and
measuring the Raman spectra of each component.
If the 1049cm-1 peak was confirmed to be the biomarker of CSC, we will use
Raman microscopy to find and characterize individual CSC and their responses to
anticancer treatments. The comparison between the responses by CSC and normal cancer
cells can help us to understand the heterogeneity of the overall cancel cell population and
facilitate the development of more effective treatments.
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